Matthew Walter

28PUBLICATIONS
195CO-AUTHORS
Gene and molecular therapyMedical infection agents (incl. prions)Liquid biopsiesRegenerative medicine (incl. stem cells)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Oct 13, 2026
TET2 loss triggers ssDNA gap accumulation and heightened PARP inhibitor sensitivity.

|Oct 06, 2026
Sensitivity to ATR-CHK1 pathway inhibition in MDS/AML is enhanced by SRSF2 mutations and reduced by RUNX1 loss.

|Jun 04, 2026
Long-read cDNA sequencing reveals novel isoforms and spliceosome-mutant-enriched transcripts in AML and MDS.

|May 06, 2026
U2af1S34F and U2af1Q157R myeloid neoplasm-associated hotspot mutations induce distinct hematopoietic phenotypes in mice.

|Apr 09, 2026
Nonsense-Mediated RNA Decay Is a Targetable Vulnerability in Splicing Factor Mutant Myeloid Neoplasms by Enhancing R-Loop Accumulation and DNA Damage.

Claudia Cabrera Pastrana, Sridhar Nonavinkere Srivatsan, Michael O Alberti

|Feb 16, 2026
Modeling the evolutionary dynamics of clonal hematopoiesis.

Sadegh Marzban, Thomas Stiehl, Zhuoer Xie

Pageof 5

Frequent Collaborators

6 joint publications

Sridhar Nonavinkere Srivatsan

6 joint publications

Christopher Miller

6 joint publications

Timothy A Graubert

3 joint publications

Jie Liu